-
321
Targets of influenza human T-cell response are mostly conserved in H5N1
Published 2025-02-01Subjects: Get full text
Article -
322
The significance of antibody to hepatitis B surface antigen in infection and clearance of hepatitis B virus
Published 2025-12-01Subjects: Get full text
Article -
323
Altered immune surveillance of B and T cells in patients with persistent residual lung abnormalities 12 months after severe COVID-19
Published 2025-01-01Subjects: Get full text
Article -
324
The composition of peripheral immunocompetent cell subpopulations and cytokine content in the brain structures of mutant Disc1-Q31L mice
Published 2020-12-01Subjects: Get full text
Article -
325
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1)
Published 2024-01-01Subjects: “…Agressive Lymphoma HIV People living with HIV Plasmablastic Lymphoma CD20-negative large B-cell Lymphoma CD38 CD138 Oral cavity lymphoma…”
Get full text
Article -
326
Effects and mechanisms of long-acting glucagon-like peptide-1 receptor agonist semaglutide on microglia phenotypic transformation and neuroinflammation after cerebral ischemia/repe...
Published 2024-12-01Subjects: “…nuclear factor kappa-light-chain-enhancer of activated b-cell signaling pathway…”
Get full text
Article -
327
Designing multi-epitope vaccines against Echinococcus granulosus: an in-silico study using immuno-informatics
Published 2024-12-01Subjects: Get full text
Article -
328
Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition
Published 2025-01-01Subjects: Get full text
Article -
329
WALDENSTRÖM MACROGLOBULINEMIA - A STATE-OF-THE-ART REVIEW: PART 1: EPIDEMIOLOGY, PATHOGENESIS, CLINICOPATHOLOGIC CHARACTERISTICS, DIFFERENTIAL DIAGNOSIS, RISK STRATIFICATION, AND C...
Published 2024-06-01Subjects: “…Amyloidosis, Anemia, B cells, BCL2, Bruton tyrosine kinase, Bing-Neel syndrome, Bruton Tyrosine Kinase Inhibitors, Cryoglobulinemia, CXCR4, flow cytometry, hyperviscosity, lymphoplasmacytic lymphoma, MYD88, Waldenström Macroglobulinemia, Peripheral neuropathy.…”
Get full text
Article -
330
Effect of Leflunomide on the Abnormal Expression of Lipid Rafts and F-Actin in B Lymphocytes from Patients with Systemic Lupus Erythematosus
Published 2015-01-01“…To investigate the possible changes in B cell subsets and in B cell expression patterns of lipid rafts (LRs) and F-actin in patients with SLE and whether leflunomide treatment may have effect on these changes. …”
Get full text
Article -
331
Grey Zone Lymphomas: Lymphomas with Intermediate Features
Published 2012-01-01“…The updated 2008 World Health Organization (WHO) classification of Tumours of the Hematopoietic and Lymphoid Tissues has addressed this problem by creation of two new provisional categories of B-cell lymphomas, unclassifiable; one with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma and the second with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma. …”
Get full text
Article -
332
Computer-Aided Design of an Epitope-Based Vaccine against Epstein-Barr Virus
Published 2017-01-01“…The T cell component includes 14 CD8 T cell epitopes from early antigens and 4 CD4 T cell epitopes, targeted during the course of a natural infection and providing a population protection coverage of over 95% and 81.8%, respectively. The B cell component consists of 3 experimentally defined B cell epitopes from gp350 plus 4 predicted B cell epitopes from other EBV envelope glycoproteins, all mapping in flexible and solvent accessible regions. …”
Get full text
Article -
333
BCL-2 inhibitors in hematological malignancies: biomarkers that predict response and management strategies
Published 2025-01-01“…Apoptosis is an essential characteristic of cancer and its dysregular promotes tumor growth, clonal evolution, and treatment resistance. B-cell lymphoma-2 (BCL-2) protein family members are key to the intrinsic, mitochondrial apoptotic pathway. …”
Get full text
Article -
334
Hepatitis C Virus Infection and Mixed Cryoglobulinemia
Published 2012-01-01“…Cytokine like CXCL13 contribute to B-cell homing in intraportal lymphoid aggregates, in which B-cell clonal selection may arise. …”
Get full text
Article -
335
Soluble Markers of Antibody Secreting Cell Function as Predictors of Infection Risk in Rheumatoid Arthritis
Published 2019-01-01“…The presence of autoantibodies and immunoglobulin abnormalities indicates B-cell and antibody-secreting cell (ASC) dysfunction. …”
Get full text
Article -
336
A Case of Chemotherapy-Refractory “THRLBCL like Transformation of NLPHL” Successfully Treated with Lenalidomide
Published 2018-01-01“…T cell histiocyte-rich large B cell lymphoma (THRLBCL), on the other hand, is a distinct entity classified under NHL and considered a variant of diffuse large B cell lymphoma (DLBCL). …”
Get full text
Article -
337
Phenotype and Function of CD25-Expressing B Lymphocytes Isolated from Human Umbilical Cord Blood
Published 2011-01-01“…We have shown that approximately 30% of human peripheral blood B-cells express CD25. B cells expressing CD25 display a mature phenotype belonging to the memory B-cell population and have a better proliferative and antigen-presenting capacity. …”
Get full text
Article -
338
Selective IgA Deficiency and Common Variable Immunodeficiency
Published 2009-09-01“…Defective T-cell activation may lead to an impairment in cognate T-B-cell interaction due to impaired expression of CD40 ligand and/or abnormalities in the production of T-cell-derived cytokines required for fully functional B-cell activation, proliferation and/or differentiation which could indeed explain the impairment in antibody production present in CVID patients. …”
Get full text
Article -
339
Connexin 43 Communication Channels in Follicular Dendritic Cell Development and in Follicular Lymphomas
Published 2015-01-01“…In follicular lymphomas B cells escape apoptosis while FDC develop abnormally. …”
Get full text
Article -
340
CAR-T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA
Published 2024-04-01“…Among these new treatments, a potentially curative approach consists of the use of chimeric antigen receptor T (CAR-T) cell therapy, which achieved remarkable success in various B-cell malignancies, including B-cell Non-Hodgkin Lymphomas (NHLs) and B-acute lymphoblastic Leukemia (ALL). …”
Get full text
Article